Ralitsa R. Madsen
Dundee, SCT DD15EH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Protocol for PI3K inhibitor-free differentiation and maturation of human iPSC-derived arterial- and venous-like endothelial cells.
Journal: STAR protocols
Published: March 30, 2026
Mosaic hotspot PIK3CA mutations cause non-cell-autonomous vascular overgrowth and pan-lineage dysregulation at disease onset.
Journal: bioRxiv : the preprint server for biology
Published: January 23, 2026
Cancer signaling beyond the genes.
Journal: Current opinion in cell biology
Published: November 30, 2025
Non-equilibrium strategies enabling ligand specificity by signaling receptors.
Journal: eLife
Published: October 29, 2025
mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node.
Journal: Orphanet journal of rare diseases
Published: November 06, 2024
Oncogenic PIK3CA corrupts growth factor signaling specificity.
Journal: Molecular systems biology
Published: October 21, 2024
Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation.
Journal: Science signaling
Published: February 27, 2024
Towards inclusive and sustainable scientific meetings.
Journal: Nature cell biology
Published: November 09, 2023
PI3K signaling through a biochemical systems lens.
Journal: The Journal of biological chemistry
Published: May 08, 2023
PIK3CA-related overgrowth: silver bullets from the cancer arsenal?
Journal: Trends in molecular medicine
Published: February 22, 2022
Precision Targeting of Mutant PI3Kα in Cancer by Selective Degradation.
Journal: Cancer discovery
Published: January 13, 2022
Last Updated: 09/26/2026